Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
1.760
-0.030 (-1.68%)
Oct 24, 2024, 4:00 PM EDT - Market closed
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $242.16 million as of October 24, 2024. Its market cap has decreased by -4.06% in one year.
Market Cap
242.16M
Enterprise Value
101.15M
1-Year Change
-4.06%
Ranking
Category
Stock Price
$1.76
Market Cap Chart
Since November 3, 2021, Compass Therapeutics's market cap has increased from $219.00M to $242.16M, an increase of 10.57%. That is a compound annual growth rate of 3.44%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 23, 2024 | 246.30M | 23.83% |
Dec 29, 2023 | 198.90M | -68.66% |
Dec 30, 2022 | 634.70M | 104.21% |
Dec 31, 2021 | 310.80M | 41.92% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Nektar Therapeutics | 265.07M |
Rigel Pharmaceuticals | 261.46M |
ESSA Pharma | 254.68M |
aTyr Pharma | 253.92M |
Sangamo Therapeutics | 251.95M |
Mersana Therapeutics | 251.48M |
Acrivon Therapeutics | 249.33M |
Inventiva | 248.11M |